In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sonus, Nycomed cross-license contrast agent patents

Executive Summary

Sonus Pharmaceuticals and Nycomed Amersham signed a cross-licensing agreement pertaining to each other's ultrasound contrast agent patents. Sonus gets (uf)$10mm--$5mm in the third quarter of 1999 and $5mm in the fourth.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Concluded
Deal Type
  • Alliance
    • Marketing (Licensing)
    • Product or Technology Swap
    • Product Purchase

Related Companies